Avanos Medical (AVNS) Accounts Payables (2016 - 2024)
Historic Accounts Payables for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $54.2 million.
- Avanos Medical's Accounts Payables rose 403.07% to $54.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $54.2 million, marking a year-over-year increase of 403.07%. This contributed to the annual value of $56.3 million for FY2023, which is 1708.39% down from last year.
- Latest data reveals that Avanos Medical reported Accounts Payables of $54.2 million as of Q3 2024, which was up 403.07% from $51.4 million recorded in Q2 2024.
- In the past 5 years, Avanos Medical's Accounts Payables registered a high of $75.9 million during Q3 2020, and its lowest value of $51.4 million during Q2 2024.
- In the last 5 years, Avanos Medical's Accounts Payables had a median value of $62.7 million in 2022 and averaged $62.3 million.
- Its Accounts Payables has fluctuated over the past 5 years, first plummeted by 5060.48% in 2020, then soared by 2039.01% in 2022.
- Avanos Medical's Accounts Payables (Quarter) stood at $67.6 million in 2020, then fell by 16.57% to $56.4 million in 2021, then rose by 20.39% to $67.9 million in 2022, then fell by 17.08% to $56.3 million in 2023, then decreased by 3.73% to $54.2 million in 2024.
- Its Accounts Payables was $54.2 million in Q3 2024, compared to $51.4 million in Q2 2024 and $57.0 million in Q1 2024.